Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Touched its 52-Week Low on Nov 28, 2016


Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has a 1 Year Target Estimate of $4.08. The stock traded with the volume of 2.83 Million in the last trading session. Tonix Pharmaceuticals Holding Corp. opened at $0.44 and closed by showing a decrease of -5.88%. The Bid price in the last session was $0.03 x 300 and the Ask price was $0.41 x 6000. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).

Tonix Pharmaceuticals Holding Corp. has the Market Capitalization of 15.67 Million. The Stock has its 52-week High of $7.95 and 52-Week Low of $0.35 and it touched its 52-week high on Jan 5, 2016 and 52-Week Low on Nov 28, 2016.

Tonix Pharmaceuticals Holding Corp. reported its last Earnings on Nov 10 where the company reported Actual EPS of $-0.29/Share whereas, the Analyst Estimated EPS was $-0.34/share. The difference between Actual EPS and Estimated EPS was $0.05/share. This represented an Earnings Surprise of 14.7%.

3 number of analysts also provided their insight on Tonix Pharmaceuticals Holding Corp., where the Average Price Target for the stock is $4.08. They also projected Low Price Target as $1 while High Price Target is set at $10.

A number of analysts rated the stock as well: 0 analysts believe that the stock is a STRONG BUY while 0 reported it as Buy.3 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.

Tonix Pharmaceuticals Holding Corp. annual Divided is 0 while it’s Dividend Yield is 0%. The stock has its Price to Earnings (P/E) ratio of 0 and Forward Price to Earnings ratio of 0. The company has its Price to Sales (P/S) ratio of 0 where Price to Book (P/B) ratio of 0.38, Price to Cash Per share (P/C) of 0.59 and Price to Free Cash Flow (P/FCF) has a value of 0.

The company has its Return on Assets (ROA) of -125.5 Percent. Return on Equity (ROE) stands at -143.4% and Return on Investment (ROI) displays a value of 0%.

The stock is currently trading at Distance from 20-Day simple moving Average of -5.92% whereas, Distance from 50-Day Simple moving average is -29.03 Percent and Distance from 200-Day Simple Moving Average of -78.49 percent.

A look at performance overview of Tonix Pharmaceuticals Holding Corp. depicts that Performance (Week) is -0.35 percent while Performance Month is -10.51%. Quarterly performance shows a value of -83.81% and Half Year Performance value stands at -83.61%. Yearly performance of the stock has the value of -94.48 percent. Tonix Pharmaceuticals Holding Corp. has its YTD performance of -94.78 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).

Insider Trades:

Many Insiders have done trades inside the company. The latest trade was made on 30 Oct 2016 where Chief Executive Officer Lederman (Seth) did a transaction type “Buy” in which 10000 shares were traded at a price of $0. Another insider trade includes Director Mario (Ernest B Ph.D.) who also initiated a transaction in which 100000 shares were traded on 30 Oct 2016 as “Buy”. On 30 Oct 2016 Director Rhodes (John B) traded 25000 shares as “Buy” at $0. Chief Executive Officer Lederman (Seth) Buy 20000 shares on 21 Jun 2016 at the price of $2.08.

Upgrades/Downgrades Report:

The latest Upgrades/Downgrades was done by Research firm ROTH Capital on 7-Sep-16 who Downgrade the stock from Buy to Neutral. Other firms have also Upgraded/Downgraded the stock. On 4-Nov-15, Cantor Fitzgerald took an action “Initiated”  to Buy. On 12-Jun-15, the stock was Initiated to Outperform by Oppenheimer.